Tested Applications
| Positive WB detected in | MCF-7 cells, T-47D cells |
| Positive IHC detected in | human skin cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | MCF-7 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
21350-1-AP targets SNAI3 in WB, IHC, IF/ICC, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag15722 Product name: Recombinant human SNAI3 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 7-186 aa of BC107058 Sequence: VKTHSSHRVPNYRRLETQREINGACSACGGLVVPLLPRDKEAPSVPGDLPQPWDRSSAVACISLPLLPRIEEALGASGLDALEVSEVDPRASRAAIVPLKDSLNHLNLPPLLVLPTRWSPTLGPDRHGAPEKLLGAERMPRAPGGFECFHCHKPYHTLAGLARHRQLHCHLQVGRVFTCK Predict reactive species |
| Full Name | snail homolog 3 (Drosophila) |
| Calculated Molecular Weight | 292 aa, 32 kDa |
| Observed Molecular Weight | 32-38 kDa |
| GenBank Accession Number | BC107058 |
| Gene Symbol | SNAI3 |
| Gene ID (NCBI) | 333929 |
| RRID | AB_2878844 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q3KNW1 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for SNAI3 antibody 21350-1-AP | Download protocol |
| IHC protocol for SNAI3 antibody 21350-1-AP | Download protocol |
| WB protocol for SNAI3 antibody 21350-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The SNAI3 Polyclonal antibody (Catalog No. 21350-1-AP) has a total of 5 citations.
Journals: Biomedicines, Front Oncol, Transl Gastroenterol Hepatol, Growth Factors, and Transl Androl Urol.
Research fields: The citations span oncology research, including ferroptosis in cisplatin-resistant oral cancer, transcription factors and immune infiltration in non-small-cell lung cancer, anti-tumour effects of ciprofol in hepatocellular carcinoma, EMT in anaplastic thyroid cancer, and RhoJ involvement in clear cell renal cell carcinoma. Most studies used the antibody for WB, with one combined WB and IF application.
| Species | Application | Title |
|---|---|---|
Biomedicines Inhibition of TPI1 Sensitizes Cisplatin-Resistant Oral Cancer to Ferroptosis | ||
Front Oncol Identifying key transcription factors and immune infiltration in non-small-cell lung cancer using weighted correlation network and Cox regression analyses
| ||
Transl Gastroenterol Hepatol Ciprofol exerts anti-tumour effects in hepatocellular carcinoma through the Raf-MEK-ERK signalling pathway | ||
Transl Androl Urol RhoJ promotes the progression of clear cell renal cell carcinoma via the TNF-α/NF-κB axis. | ||
Growth Factors MiR-200c regulates invasion, proliferation and EMT of anaplastic thyroid cancer cells by targeting parathyroid hormone like hormone |









